Navigation » List of Schools » Glendale Community College » Medical Office Administration » MOA 193 – Current Procedural Term Coding » Spring 2023 » Weekly Assignment 4
Below are the questions for the exam with the choices of answers:
Question #1
A 22556 62
B 22845
C 63077 51
D 122585 62
Question #2
A Global period concept does not apply to code 28046.
B 0 days
C 10 days
D 90 days
Question #3
A A chronic, noncontagious disease that affects the digestive system and causes abdominal pain and diarrhea.
B A chronic, noncontagious disease characterized by inflamed lesions covered with silvery-white scabs of dead skin.
C A contagious disease caused by a virus that attacks the liver.
D A chronic, noncontagious disease that affects the lungs and causes difficulty in breathing.
Question #4
A A tumor formed of nerve tissue, typically occurring in the brain.
B A tumor formed of muscle tissue, typically occurring in the heart.
C A tumor formed of mixed fibrous and glandular tissue, typically occurring as a benign growth in the breast.
D A tumor formed of bone tissue, typically occurring in the limbs.
Question #5
A A gland that produces saliva in the mouth.
B A gland in the skin that secretes a lubricating oily matter into the hair follicles.
C A gland in the skin that produces sweat.
D A gland that produces hormones in the thyroid.
Question #6
A The removal of a tumor using a scalpel.
B The removal of a foreign object from the eye using a cotton swab.
C The removal of fluid or tissue from a body cavity or organ using suction.
D The removal of a bone fracture using a cast.
Question #7
A The removal of scar tissue from a surgical site.
B The removal of healthy tissue from a wound to prevent infection.
C The removal of foreign material and devitalized or contaminated tissue from a wound to expose healthy tissue.
D The application of a dressing to a wound to promote healing.
Question #8
A The death of cells or tissues from severe injury or disease, especially in a localized area of the body.
B The formation of scar tissue in response to injury or disease.
C The abnormal growth of cells, which may be cancerous or noncancerous.
D The inflammation of a joint, typically accompanied by pain, swelling, and stiffness.
Question #9
A Denoting a contagious character of an illness or neoplasm.
B Denoting a severe character of an illness or malignant character of a neoplasm.
C Denoting a mild character of an illness or nonmalignant character of a neoplasm.
D Denoting a hereditary character of an illness or neoplasm.
Question #10
A The process of visualizing the inside of a joint or body cavity using an endoscope.
B The process of removing tissue from a patient for diagnostic examination.
C The process of surgically removing a portion of the liver.
D The process of repairing a hernia by placing a mesh patch over the weakened area.
Question #11
A Fibrosis
B Synarthrosis
C Diarthrosis
D Amphiarthrosis
Question #12
A A cyst containing mucopolysaccharide-rich fluid within fibrous tissue, usually attached to a tendon sheath in the hand, wrist, or foot, or connected with the underlying joint.
B A type of tumor that originates in the connective tissue
C A noncancerous growth that develops in the skin or subcutaneous tissue
D A fluid-filled sac that develops in the synovial lining of a joint
Question #13
A Two times
B Three times
C It depends on the number of injections given.
D One time
Question #14
A The injection of a fluid into a joint for therapeutic purposes
B The aspiration of fluid from a joint performed by needle puncture
C The insertion of a scope into a joint to visualize the joint cavity
D The removal of a joint for surgical repair
Question #15
A Excision of the gallbladder.
B Excision of the appendix.
C Excision, in part or whole, of an intervertebral disk.
D Excision of the thyroid gland.
Question #16
A Use of radiation to destroy abnormal or diseased tissue.
B Use of electricity in surgery to destroy abnormal or diseased tissue.
C Use of extreme cold in surgery to destroy abnormal or diseased tissue.
D Use of heat in surgery to destroy abnormal or diseased tissue.
Question #17
A Yes, the debridement is reported separately when a tissue-cultured autograft is performed.
B It depends on the size of the wound being treated.
C No, the debridement is not reported separately when a tissue-cultured autograft is performed.
D It depends on the extent of the debridement performed.
Question #18
A Report the debridement code 97597 for 33 sq cm and the wound care management code 97598 for the entire wound.
B Report the debridement code 97597 for 33 sq cm and the application of a compression bandage code 29581.
C Report the debridement code 97597 for 33 sq cm, the wound care management code 97598 for the entire wound, and the application of a compression bandage code 29581.
D Report only the debridement code 97597 for 33 sq cm.
Question #19
A Report both the surface area of the wound and the surface area that was debrided.
B Report the total surface area of the wound.
C Report only the surface area of the wound that was not debrided.
D Report only the surface area of the wound that was debrided.
Question #20
A The surface area of the wound before debridement
B The surface area of the wound plus the surrounding skin
C The surface area of the surrounding skin
D The surface area of the wound after debridement